A team of researchers at Kyushu University in Japan in the latest issue of the US “Clinical examination magazine” reported that they found in animal studies for the treatment of chronic hepatitis B, to curb cancer metastasis.
In recent years, many researchers have found that in cancer metastasis, some normal cells around it will be gradually transformed into a population of cells, thus helping cancer cell proliferation and metastasis. The “group” in the growth of cancer cells secrete either an indispensable ingredient, or to curb those immune cells to attack cancer cells.
After this analysis also showed that this cell population is produced by fibroblasts and mononuclear white blood cells among the cells. Which will be a lot of fibroblasts secrete a code-named “CCL2” proteins, the latter will be attracted monocytes Group “group.”
The researchers noted that due to similar mechanisms of protein in these activities CCL2 certain characteristics and inflammation caused by the hepatitis B virus, the researchers let the mice administered hepatitis B therapy propionate Pa germanium, metastatic breast cancer cells and found that the number of such animals Therefore, the original will be reduced to one tenth, while a malignant skin cancer – melanoma metastasis number fell to a quarter of the original.
The research team also found that mice given after taking propionate Pa germanium assist cancer metastasis monocytes reactions do not occur on the protein and CCL2, unable to form a “accomplice” The role of the cell population, thus significantly curb the proliferation of cancer cells.